Sanofi Files 2024 Financial Reports with SEC and AMF

Sanofi has announced the filing of its 2024 Form 20-F with the U.S. Securities and Exchange Commission, alongside the “Document d’Enregistrement Universel” with France's Autorité des marchés financiers. These filings encompass the company's comprehensive audited financial statements, available on Sanofi's website, as well as the SEC and AMF websites.

These documents provide transparency into Sanofi's financial performance and regulatory compliance. Interested parties can request a hard copy free of charge. This step underscores Sanofi's commitment to meet regulatory standards both in the U.S. and France, ensuring stakeholders are well-informed.